BOSTON and ROLLE, Switzerland, April 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader…
CHICAGO, April 28, 2025 /PRNewswire/ -- New research published in Cancer Research and presented today at the AACR Annual Meeting 2025 shows that…
SPOKANE, Wash., April 28, 2025 /PRNewswire/ -- Gestalt, a leading innovator in AI-powered digital pathology solutions, announced the completion of a…
Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology Accelerating multiple late-stage cancer therapies…
Collaboration Projected To Generate Around $10 Million In Revenue Over The Next Three Years NEW YORK, April 28, 2025 /PRNewswire/ --…
New National Survey Reveals How Emotional Isolation Threatens Patient Health LAS VEGAS, April 28, 2025 /PRNewswire/ -- Today, at the Asembia…
Investment comes at a pivotal moment for Alpha Tau, which is experiencing remarkable growth on multiple fronts, with four active…
Ten (10) patients have achieved an objective response (5 confirmed) when treated with MDNA11 alone or in combination with KEYTRUDA®…
New Data Suggest SLS009 (tambiciclib) May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK,…
ART26.12 Phase 1 in healthy volunteers completes enrollment with clinical data announcement expected this quarterSOLANA BEACH, Calif., April 28, 2025 (GLOBE…